Ligand · V6M
V6M · 7-methyl-3-phenyl-1H-indole-2-carboxylic acid
V6M, 7-methyl-3-phenyl-1H-indole-2-carboxylic acid (C16 H13 N O2, 251.3 g/mol), in the MolNFT structures on GenesisL1: bound in 6 records (3 PDB entries). Every binding site with its residues within 4.5 Å, the residues it binds most and…
- Component
- V6M
- Formula
- C16 H13 N O2
- Class
- ligand
- Structures
- 6
- PDB entries
- 3
Binding sites
V6M in 6 structures; the first of them:
- 6XQ5 · Receptor for Advanced Glycation End Products VC1 domain in complex with Fragment 1 · V6M A306 · binds ALA21, GLU50, TRP51, LYS52, ARG98, CYS99, GLN100, LYS110 and 2 more
- 6XQ8 · Receptor for Advanced Glycation End Products VC1 domain in complex with Fragments 1 & 11 · V6M A305 · binds ALA21, GLU50, TRP51, LYS52, ARG98, CYS99, GLN100, LYS110 and 2 more
- 6XQ9 · Receptor for Advanced Glycation End Products VC1 domain in complex with Fragments 1 & 13 · V6M A305 · binds ALA21, GLU50, LYS52, ARG98, CYS99, GLN100, LYS110, SER111 and 1 more
- 6XQ5 · Receptor for advanced glycation end products VC1 domain in complex with fragment 1 · V6M A306 · binds ALA21, GLU50, LYS52, ARG98, CYS99, GLN100, LYS110, SER111 and 1 more
- 6XQ8 · Receptor for advanced glycation end products VC1 domain in complex with fragments 1 & 11 · V6M A305 · binds ALA21, GLU50, LYS52, ARG98, CYS99, GLN100, LYS110, SER111 and 1 more
- 6XQ9 · Receptor for advanced glycation end products VC1 domain in complex with fragments 1 & 13 · V6M A305 · binds ALA21, GLU50, LYS52, ARG98, CYS99, GLN100, LYS110, SER111 and 1 more
Residues it binds most
LYS 12, ALA 12, ARG 12, ASN 12, CYS 12, GLN 12, GLU 12, SER 12, TRP 4 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.